Connecting Early Stage Products with Capital & Channel Partners

The Redefining Early Stage Investments (RESI) conference series connects start-ups and early-stage investors and strategic channel partners. RESI is a unique and powerful tool for sourcing assets and advancing innovation across early-stage life science and healthcare.

Eurocine Vaccines will participate to connect with innovators in companies and academy to reveal new vaccine candidates for possible collaborations.

Are you a vaccine innovator with a promising vaccine candidate? Connect with us via the partnering system or drop us an e-mail at info@eurocine-vaccines.com!